01
Several fragmented operators in one discipline that would be priced as a platform.
INDUSTRIES
Healthcare & Life Sciences
The sector is full of strong individual operators and very few of them at scale. We work with clinical groups and life-sciences businesses that have proven the model and stalled at the point where growth requires capital and structure the owner does not have. The value is real. The path to realising it is the missing part.
Fragmented operators in the same discipline are worth more together than apart, and founder-clinicians often reach a succession point with no structured way out. Both are the work we do.
We pursue roll-ups of fragmented clinical and services operators, and growth capital for groups past proof but short of scale.
We pursue roll-ups of fragmented clinical and services operators, and growth capital for groups past proof but short of scale.
01
01
Where we engage
—
Consolidation of fragmented clinical and services operators into a single platform
—
Growth capital for groups past proof of model but short of institutional scale
—
Succession and liquidity for founder-owners with no structured path out
—
Co-investment alongside the firm on platform builds in the sector
—
Cross-border structuring where operations span jurisdictions
Typical situations
Typical Situations
02
A healthcare group that has proven its model but cannot reach the scale capital wants on its own.
03
A founder-clinician at a succession point with no buyer and no structure in place.
If this is the position, it is worth a conversation.